Work with our internationally recognized faculty to explore the science of infectious disease. Our focus on mentoring and teamwork will support your training.
We study a wide variety of viruses, including papillomaviruses, HIV and HCMV. We aim to understand and prevent viral infection and to develop antiviral therapies.
At the start of the pandemic, research teams around the world began conducting studies to help further research related to vaccines for the SARS-CoV-2 coronavirus. A team led by Jonathan F. Lovell, PhD, was one of them.
Joseph Terrell Smith Jr., PhD, postdoctoral fellow in microbiology and immunology, has been awarded a three-year, $202,000 F32 grant from the National Institute of Allergy and Infectious Diseases to study the regulation of RNA in Trypanosoma brucei.
Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a computational approach to make drug discovery faster and less expensive while also being safe and effective.
Michael W. Russell, PhD, professor emeritus of microbiology and immunology, says more COVID-19 studies should be devoted to how immunity emerges to SARS-CoV-2 in the mucous membranes of the nose and mouth.
Agents that enhance the immune response to foreign molecules, called adjuvants, will likely play a role in developing a successful COVID-19 vaccine, according to Terry D. Connell, PhD, professor of microbiology and immunology.
Nine faculty members and a staff member from the Jacobs School of Medicine and Biomedical Sciences were among those honored for notable achievement and service at the 17th annual University at Buffalo Celebration of Faculty and Staff Academic Excellence.
Researchers exploring the nature of immunity after vaccination against Streptococcus pneumoniae have discovered that a specific type of white blood cell called neutrophils plays a more critical role than was previously known.
The PhD Program in Biomedical Sciences (PPBS) recognized 14 students from the Class of 2019-2020 — 11 doctoral students and three MD-PhD Program students — who completed their first year in the program and are moving on to their research laboratory match.
